Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system

Academic Article


  • INTRODUCTION: In view of the limited success of available treatment modalities for metastatic breast cancer, alternative and complementary strategies need to be developed. Adenoviral vector mediated strategies for breast cancer gene therapy and virotherapy are a promising novel therapeutic platform for the treatment of breast cancer. However, the promiscuous tropism of adenoviruses (Ads) is a major concern. Employing tissue specific promoters (TSPs) to restrict transgene expression or viral replication is an effective way to increase specificity towards tumor tissues and to reduce adverse effects in non-target tissues such as the liver. In this regard, candidate breast cancer TSPs include promoters of the genes for the epithelial glycoprotein 2 (EGP-2), cyclooxygenase-2 (Cox-2), alpha-chemokine SDF-1 receptor (stromal-cell-derived factor, CXCR4), secretory leukoprotease inhibitor (SLPI) and survivin.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Stoff-Khalili MA; Stoff A; Rivera AA; Banerjee NS; Everts M; Young S; Siegal GP; Richter DF; Wang M; Dall P
  • Start Page

  • R1141
  • End Page

  • R1152
  • Volume

  • 7
  • Issue

  • 6